Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01539512 |
|---|---|
| Brief Title: | A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) |
| First Submitted : | February 12, 2012 |
| First Submitted that Met QC Criteria : | February 24, 2012 |
| First Posted : | February 27, 2012 (Estimate) |
| Results First Submitted : | October 9, 2014 |
| Results First Submitted that Met QC Criteria : | October 9, 2014 |
| Results First Posted : | October 16, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 1, 2019 |
| Last Update Posted : | May 14, 2019 |